Literature DB >> 11853690

Differential effects of 4-aminoquinoline-containing antimalarial drugs on hemoglobin digestion in Plasmodium falciparum-infected erythrocytes.

Oleg Famin1, Hagai Ginsburg.   

Abstract

Several reports suggest that the antimalarial mode of action of quinoline drugs may differ in their mechanistic details. The malaria parasite Plasmodium falciparum was treated in culture with chloroquine, amodiaquine, quinine and mefloquine in a dose- and time-dependent fashion. After removal of the drug, the viability of the parasites and their hemoglobin content were determined. Whereas in the presence of chloroquine and amodiaquine, there was a correlation between parasite killing and accumulation of hemoglobin, with quinine and mefloquine parasite killing was not associated with the accumulation of hemoglobin. Mefloquine inhibited the chloroquine-dependent accumulation of hemoglobin. It is suggested that whereas chloroquine and amodiaquine inhibit the digestion of hemoglobin, mefloquine and possibly quinine inhibit the ingestion of host cell hemoglobin by interfering with the ingestion process. These results may explain the demonstrable antagonism between chloroquine and mefloquine and their antipodal sensitivity to these drugs.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11853690     DOI: 10.1016/s0006-2952(01)00878-4

Source DB:  PubMed          Journal:  Biochem Pharmacol        ISSN: 0006-2952            Impact factor:   5.858


  22 in total

1.  Accelerated denaturation of hemoglobin and the antimalarial action of chloroquine.

Authors:  Coy D Fitch; Natrice V Russell
Journal:  Antimicrob Agents Chemother       Date:  2006-07       Impact factor: 5.191

2.  Differential effects of quinoline antimalarials on endocytosis in Plasmodium falciparum.

Authors:  Lindi Roberts; Timothy J Egan; Keith A Joiner; Heinrich C Hoppe
Journal:  Antimicrob Agents Chemother       Date:  2008-03-03       Impact factor: 5.191

3.  The antimalarial amodiaquine causes autophagic-lysosomal and proliferative blockade sensitizing human melanoma cells to starvation- and chemotherapy-induced cell death.

Authors:  Shuxi Qiao; Shasha Tao; Montserrat Rojo de la Vega; Sophia L Park; Amanda A Vonderfecht; Suesan L Jacobs; Donna D Zhang; Georg T Wondrak
Journal:  Autophagy       Date:  2013-10-08       Impact factor: 16.016

4.  Population pharmacokinetics and pharmacodynamic considerations of amodiaquine and desethylamodiaquine in Kenyan adults with uncomplicated malaria receiving artesunate-amodiaquine combination therapy.

Authors:  Vincent Jullien; Bernhards Ogutu; Elizabeth Juma; Gwenaelle Carn; Charles Obonyo; Jean-René Kiechel
Journal:  Antimicrob Agents Chemother       Date:  2010-04-05       Impact factor: 5.191

5.  Amodiaquine and artemether-lumefantrine select distinct alleles of the Plasmodium falciparum mdr1 gene in Tanzanian children treated for uncomplicated malaria.

Authors:  G S Humphreys; I Merinopoulos; J Ahmed; C J M Whitty; T K Mutabingwa; C J Sutherland; R L Hallett
Journal:  Antimicrob Agents Chemother       Date:  2006-12-28       Impact factor: 5.191

6.  Multi-omic Characterization of the Mode of Action of a Potent New Antimalarial Compound, JPC-3210, Against Plasmodium falciparum.

Authors:  Geoffrey W Birrell; Matthew P Challis; Amanda De Paoli; Dovile Anderson; Shane M Devine; Gavin D Heffernan; David P Jacobus; Michael D Edstein; Ghizal Siddiqui; Darren J Creek
Journal:  Mol Cell Proteomics       Date:  2019-12-13       Impact factor: 5.911

7.  A controlled trial to assess the effect of quinine, chloroquine, amodiaquine, and artesunate on Loa loa microfilaremia.

Authors:  Joseph Kamgno; Patrick Nguipdop Djomo; Sébastien D Pion; Björn Thylefors; Michel Boussinesq
Journal:  Am J Trop Med Hyg       Date:  2010-03       Impact factor: 2.345

8.  Microwave-assisted, rapid synthesis of 2-vinylquinolines and evaluation of their antimalarial activity.

Authors:  Guang Huang; Claribel Murillo Solano; Yuxin Su; Nameer Ezzat; Shino Matsui; Liuyu Huang; Debopam Chakrabarti; Yu Yuan
Journal:  Tetrahedron Lett       Date:  2019-05-28       Impact factor: 2.415

9.  Defining the timing of action of antimalarial drugs against Plasmodium falciparum.

Authors:  Danny W Wilson; Christine Langer; Christopher D Goodman; Geoffrey I McFadden; James G Beeson
Journal:  Antimicrob Agents Chemother       Date:  2013-01-14       Impact factor: 5.191

10.  Amino acid efflux by asexual blood-stage Plasmodium falciparum and its utility in interrogating the kinetics of hemoglobin endocytosis and catabolism in vivo.

Authors:  Seema Dalal; Michael Klemba
Journal:  Mol Biochem Parasitol       Date:  2015-07-26       Impact factor: 1.759

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.